Why the study?
Is acute schizophrenia associated with altered heart rate variability and vagal efferent activity compared to matched controls?
Is acute schizophrenia associated with altered heart rate variability and vagal efferent activity compared to matched controls?
Acute schizophrenia is associated with a loss of efferent vagal activity, which may contribute to the increased risk of arrhythmias and sudden cardiac death in this population.
Answers are grounded in this paper and cite their sources.
Acute schizophrenia-associated vagal loss may raise arrhythmia risk; leaves open whether HRV monitoring or interventions alter outcomes.
Increased heart rate has been reported in schizophrenia. It is unclear whether this is due to disease-related autonomic nervous system changes or a side effect of antipsychotic medication. Altered cardiac autonomic function might to some extent account for the elevated cardiovascular mortality rate of schizophrenic patients. We assessed heart rate variability (HRV) in 30 acute unmedicated schizophrenic patients and matched controls. Patients were re-investigated 2–4 days after initiation of treatment to assess effects of medication. Our study demonstrates that schizophrenic patients were significantly different in heart rate (increase) and parasympathetic parameters (loss of efferent vagal activity) at rest and during deep respiration. No significant effect was found after initiation of neuroleptic therapy. We found a correlation between duration of disease and parasympathetic parameters as well as very low frequency power (VLF) and delusion (SAPS subscale). These data suggest that schizophrenia is accompanied by a loss of vagal efferent activity, probably due to disturbed cortical-subcortical circuits modulating the autonomic nervous system in acute psychosis. The definite mechanisms by which vagal activity might be suppressed in schizophrenia are unknown. Parasympathetic hypoactivity might increase the risk for sudden cardiac death and arrhythmias in this disease. Future studies are warranted to investigate the interaction between cardiac autonomic function and schizophrenia and to identify patients at risk.
No takes yet. Share an insight, caveat, or question.
Bär et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: